I really don't want to be a doctor

Chapter 408
Ordinary people at the age of 20 are still sound asleep in the dormitory. Even an excellent student like Irina is just dissecting mice in the laboratory.

"Mr. Peter, the boss of the Shenzhou Laboratory should be a rich second generation?" Irina asked aloud, "Otherwise, no matter how talented he is, he will not be able to control such a large laboratory."

Peter stopped, shook his head slightly and said: "No, as far as I know, the boss of Shenzhou Laboratory sold the patent rights to Pfizer after developing a new type of oral anticoagulant drug, and Pfizer helped him prepare this Top lab."

"Pfizer? No wonder..." Irina's eyes lit up. If she could get in touch with a giant pharmaceutical company like Pfizer, her future achievements would be absolutely limitless.

"The important thing is not Pfizer." Peter said, "It's the new oral anticoagulant drug, haven't you heard of this?"

Irina shook her head suspiciously.

Her major is tumor pharmacy, and she doesn't know much about anticoagulant drugs.

"Let's put it this way, you should know about warfarin."

"I know." Irina nodded.

Peter explained: "Warfarin is an anticoagulant drug. The disadvantage is that the INR needs to be maintained between 2-3 to exert its efficacy. The new oral anticoagulant drugs do not need to monitor the INR."

Warfarin is an old drug that has been used clinically for many years, and Irina still knows a lot about warfarin.

Anticoagulant drugs are widely used clinically, but the application of warfarin is greatly limited because of the need to monitor INR.

This new oral anticoagulant drug solves one of the biggest shortcomings of warfarin!
Irina can imagine that the new oral anticoagulant will definitely replace warfarin and become the most widely used anticoagulant in clinical practice.

"A new type of oral anticoagulant is on the market?" Irina said.

"Yes." Peter nodded, "After three years of clinical trials, it was officially launched globally some time ago."

"Hey, that's really a pity." Irina sighed, "If the boss of Shenzhou Laboratory didn't sell this patent right back then, and cooperated with the pharmaceutical company or signed a sharing contract, it would definitely make a lot of money Full."

……

Peter and Irina were chatting on the side, although they were using English, Luo Xin could still understand the general idea.

At this time, Luo Xin's heart was turbulent. She originally thought that Jing Xiaoran was hired by Pfizer to become the person in charge of the Shenzhou Laboratory.

Most of them think this way too.

Unexpectedly, Jing Xiaoran is the owner of Shenzhou Laboratory!
Just relying on the transfer of a drug patent, he got a world-class laboratory, which Luo Xin could never have dreamed of!

Luo Xin felt that she had already overestimated Jing Xiaoran, and regarded him as a goal that would never be possible to catch up with, but only now did she realize that she still "underestimated" Jing Xiaoran.

"Student, take me to another laboratory."

After a while, Peter's voice sounded, and Luo Xin regained her inner shock.

"okay."

Go up to the third floor, which is considered to be the core area of ​​the entire laboratory.

Jeffrey's "Myocardial Mesenchymal Stem Cell" laboratory is on the third floor.

There are not many people in Shenzhou Laboratory. Today, most of them are concentrated in the lobby on the first floor. Not many people are working in the laboratory at this time.

Luo Xin led Peter and Irina to visit several laboratories.

"I found that many laboratories are idle." Peter said.

"Mr. Peter, because our Shenzhou Laboratory has just been established, there are not enough staff." Luo Xin smiled, "There are many experimental projects that are still short of manpower."

"That's right, you've been established for less than half a year." Peter chuckled, "But with the current results, it's pretty good."

"Thank you teacher for your compliment." Luo Xin continued, "The tour is over here, shall we go downstairs?"

"it is good."

Just as Peter was about to turn around and leave, he inadvertently caught a glimpse of a closed laboratory with the "cardiac stem cell" project team marked on the door.

Seeing Peter stop, Luo Xin followed his gaze.

"Mr. Peter, this is the project team's laboratory on cardiac stem cells in our laboratory."

Peter was a little puzzled, "Myocardial stem cells?"

Irina on the side also said: "Hasn't myocardial stem cells been proven to be a false proposition? Why are you still doing related research here?"

The myocardial stem cell technology of Professor Piero Anversa has been proven to be academic fraud, and countless related research institutes around the world have been closed down.

Because of Professor Piero Anversa's status as a Harvard professor and a frequent visitor to Nature magazine, this academic fraud caused a sensation in the global academic community!

Of course, Luo Xin also knew about this academic fraud case, she quickly explained: "I'm talking about myocardial mesenchymal stem cells, not myocardial stem cells."

"Myocardial mesenchymal stem cells?"

Peter was at a loss, he had never heard the related vocabulary.

Irina also shook her head suspiciously.

"I don't know how to explain it either." Luo Xin said.

She has only been in contact with it, and does not know the specific situation of the myocardial mesenchymal stem cell project.

"Then can we go in and have a look?" Peter suggested.

The entire Shenzhou laboratory has made sufficient preparations for today's meeting. After all, it is to receive foreign friends. Zhu Xianqing and Lin Yitian ordered all the experimental materials to be sorted out and not exposed.

"Of course." Luo Xin nodded.

There should be no one in the laboratory now, everyone is concentrated in the hall on the first floor.

Luo Xin stepped forward and gently pushed open the door of the laboratory.

……

During the experiment, Jeffrey was sorting out relevant materials in the laboratory, and he had promised Jing Xiaoran to speak at the meeting.

Because time is tight, he still has the last part of the experimental conclusion unfinished.

"I heard that the person who came here today is also a researcher from a laboratory in the United States." Jeffrey murmured in his heart while working on the laboratory.

A year ago, when he decided to leave Lawrence Berkeley National Laboratory and come to Huaxia, many colleagues and teachers thought he was crazy.

Even now, he has posted several high-scoring SCI articles in a row, but he is still not recognized by his friends and teachers.

In the eyes of others, Huaxia's thesis is just flooding and falsification.

(End of this chapter)